A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Clinical trial NCT03314935 · COMPLETED

Trial details

NCT number: NCT03314935
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer (BTC)Colorectal Cancer (CRC)Endometrial Cancer Gastroesophageal Cancer (GC)Ovarian Cancer Solid Tumors

Start date: 2017-11-21
Primary completion: 2022-11-28
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.